The approval of brensocatib for use in patients with bronchiectasis could offer the first treatment directly addressing the ...

An estimated 5.17% of patients with inflammatory bowel diseases also have bronchiectasis, as shown in chest CT scans of patients with IBD.

Long-term antibiotics use carries the risk of resistance and side effects, representing a gap in the market for a different ...

Bronchiectasis is a chronic airway suppurative disease in which recurrent airway infections, inflammation and remodeling have ...

The prospective study enrolled 30 paediatric CF patients who underwent imaging and spirometry both before and following the ...

Objective: Surgical resection remains the gold standard treatment for bronchiectasis in patients who present with hemoptysis or suppuration, as well as in those who do not respond to clinical ...

Experts at the University of Dundee have announced promising results from a clinical trial of a potential new antibody ...

qPCR was performed for MUC2, interleukin (IL)-6, IL-1β and tumour necrosis factor α. Results In rats, PAS/AB and MUC2/DBA staining revealed mucus layer detachment at ischaemia which was accompanied by ...

By Hilary Brown University of Kentucky Lyndsey Minch Allnutt couldn’t remember a time when she couldn’t stop coughing or ...

Diseases that cause excessive mucus production include chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, and cystic fibrosis. Sometimes called chronic mucus hypersecretion or ...

The leading Bronchiectasis Companies such as AstraZeneca, Insmed Incorporated, SolAeroMed, Boehringer Ingelheim, CSL Behring, Thirty Respiratory Limited, RedHill Biopharma Limited, Chiesi Farmaceutici ...

Disease severity was assessed, including exacerbation frequency, measurement of airway inflammatory markers, sputum bacteriology and lung function over 3 years follow-up. Conclusions Vitamin-D ...